Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies.

UNLABELLED The use of dynamic (18)F-FDG PET to determine changes in tumor metabolism requires tumor and plasma time-activity curves. Because arterial sampling is invasive and laborious, our aim was to validate noninvasive image-derived input functions (IDIFs). METHODS We obtained 136 dynamic (18)F-FDG PET scans of 76 oncologic patients. IDIFs were determined using volumes of interest over the left ventricle, ascending aorta, and abdominal aorta. The tumor metabolic rate of glucose (MRGlu) was determined with the Patlak analysis, using arterial plasma time-activity curves and IDIFs. RESULTS MRGlu using all 3 IDIFs showed a high correlation with MRGlu based on arterial sampling. Comparability between the measures was also high, with the intraclass correlation coefficient being 0.98 (95% confidence interval, 0.97-0.99) for the ascending aorta IDIF, 0.94 (0.92-0.96) for the left ventricle IDIF, and 0.96 (0.93-0.98) for the abdominal aorta IDIF. CONCLUSION The use of IDIFs is accurate and simple and represents a clinically viable alternative to arterial blood sampling.

[1]  E. Hoffman,et al.  Validation of PET-acquired input functions for cardiac studies. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  Mark Muzi,et al.  Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  R L Wahl,et al.  Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M E Phelps,et al.  Correction of spillover radioactivities for estimation of the blood time-activity curve from the imaged LV chamber in cardiac dynamic FDG PET studies. , 1995, Physics in medicine and biology.

[5]  A. A. Lammertsma,et al.  On the use of image-derived input functions in oncological fluorine-18 fluorodeoxyglucose positron emission tomography studies , 1999, European Journal of Nuclear Medicine.

[6]  A. Lammertsma,et al.  Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  Martin A. Lodge,et al.  Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions , 1999, European Journal of Nuclear Medicine.

[8]  M. Schwaiger,et al.  Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  R. Boellaard,et al.  Measurement of 18F-FDG concentrations in blood samples: comparison of direct calibration and standard solution methods. , 2003, Journal of nuclear medicine technology.

[10]  M. Phelps,et al.  Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  M E Phelps,et al.  Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  D. Visvikis,et al.  Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  Michael E. Phelps,et al.  Quantitation in Positron Emission Computed Tomography , 1980 .

[15]  E. Hoffman,et al.  Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  Cyrill Burger,et al.  Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.